Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- Versus 48-h incubation and 50 versus 80% reduction in growth

Mycoses

Volumn 44, Issue 1-2, 2001, Pages 37-45

  St Germain, G ^a  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Candida; Endpoint; Susceptibility testing

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CONTROLLED STUDY; DISEASE COURSE; DRUG SENSITIVITY; FUNGUS GROWTH; GROWTH INHIBITION; IC 50; INCUBATION TIME; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL;

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS; FUNGI;

EID: 0035003856     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2001.00603.x     Document Type: Article

References (16)

1. Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans
2. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards Method
3. Optimising the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
4. Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazde
5. Fluconazole susceptibility testing of Candida species: Growth inhibition patterns at 24 and 48 h
6. Quality, control guidelines for National Committee for Laboratory Clinical Standards recommended broth macrodilution testing of amphotericin B, fluconazole and flucytosine
7. Antifungal susceptibility, testing
8. Antifungal susceptibility, testing of yeasts: Evaluation of technical variables for test automation
9. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B
10. Do in vitro susceptibility data predict the microbiologic response to amphotericin B?
11. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates
12. Antifungal susceptibility of yeasts: A brief overview
13. The trailing endpoint phenotype in antifungal susceptibility testing is pH dependent
14. Rapid, transient fluconazole resistance in Candida albicans is associated with increased MRNA levels of CDR
15. Azole resistance in Candida